At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Trial of Focal Therapy in the Treatment of Patients With 1-3 Brain Metastases
Ohio State University Comprehensive Cancer Center·interventional·Posted Sep 24, 2009·Updated Jun 6, 2017
In Brief
A clinical study evaluating Radiation Therapy for Metastatic Cancer and Unspecified Adult Solid Tumor, Protocol Specific. Completed, enrolled 40 participants across 1 site.
Detailed Summary
RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase II trial is study how well stereotactic radiation therapy works in treating patients with brain metastases
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedSep 2009
Primary CompletionAug 2012
TodayJul 2026
First PostedSep 24, 2009
Enrollment StartApr 1, 2007
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 16.8 years ago
Interventions
Radiation Therapyradiation
Patients undergo conformal stereotatic radiation therapy QD (every day) over 5 days.